# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 17: Amendment of regulation 36 (requirement for authorisation to manufacture or import investigational medicinal products)


In regulation 36(2), before “marketing authorization” insert “UK”.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/17 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.